YAKOV D SHAPOSHNIKOV

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology LAS VEGAS, NV NPI 1790710994

General Payments — all program years on this page

$2,596.53

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 107
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $663.67 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $663.6717

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $350.5217
2019 $543.4017
2020 $133.178
2021 $381.1517
2022 $217.9113
2023 $306.7118
2024 $663.6717

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078394247 Janssen Biotech, Inc. $14.25 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078395232 Janssen Biotech, Inc. $22.34 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078395726 Janssen Biotech, Inc. $18.05 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123325719 Mirum Pharmaceuticals, Inc. $21.92 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135518680 Lilly USA, LLC $33.75 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137673669 Takeda Pharmaceuticals U.S.A., Inc. $23.41 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139641084 GENZYME CORPORATION $23.05 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139641122 GENZYME CORPORATION $20.46 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139641156 GENZYME CORPORATION $12.14 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139641176 GENZYME CORPORATION $130.02 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139641194 GENZYME CORPORATION $13.99 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139641224 GENZYME CORPORATION $15.81 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144182163 Madrigal Pharmaceuticals $142.79 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146967073 AIMMUNE THERAPEUTICS, INC. $16.39 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146967371 AIMMUNE THERAPEUTICS, INC. $16.39 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151124570 Phathom Pharmaceuticals, Inc. $18.66 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151124572 Phathom Pharmaceuticals, Inc. $120.25 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.